Cassava Sciences Appoints Jack Moore as Senior Vice President, Clinical Development
Position
Vice President of Clinical Development
Company
Cassava Sciences
AustinBiotechnologyHealth CareDescription
Cassava Sciences, Inc announces the appointment of Jack Moore, PhD, as Senior Vice President, Clinical Development. This role will be effective April 28, 2025, following the retirement of their Chief Medical Officer, James W Kupiec, MD, effective May 9, 2025.
Quick answer
Cassava Sciences Appoints Jack Moore as Senior Vice President, Clinical Development (April 21, 2025). Cassava Sciences is based in Austin, Texas, United States.
- Who is the new Vice President of Clinical Development at Cassava Sciences?
- Cassava Sciences named Jack Moore Vice President of Clinical Development, announced April 21, 2025.
- What did Cassava Sciences announce on April 21, 2025?
- Cassava Sciences, Inc announces the appointment of Jack Moore, PhD, as Senior Vice President, Clinical Development. This role will be effective April 28, 2025, following the retirement of their Chief Medical Officer, James W Kupiec, MD, effective May 9, 2025.
- What does Cassava Sciences do?
- Cassava Sciences, Inc. (NASDAQ: SAVA), is a clinical-stage biotechnology company focused on developing novel, investigational treatments, including simufilam, for central nervous system disorders such as tuberous...
- Where is Cassava Sciences based?
- Cassava Sciences is based in Austin, Texas, United States.
- Which similar companies made leadership changes around the same time?
- AEON Biopharma (April 22, 2025), Neurizon Therapeutics (April 22, 2025), DarioHealth (April 21, 2025) and Suanfarma (April 22, 2025) also announced leadership changes within 45 days of Cassava Sciences.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AEON Biopharma Appoints Rob Bancroft as Chief Executive Officer (April 22, 2025)
- Neurizon Therapeutics Appoints Dan O’Connell as Chief Financial Officer (April 22, 2025)
- DarioHealth Appoints Chen Franco-Yehuda as Chief Financial Officer (April 21, 2025)
- Suanfarma Appoints Pere Mañé Godina as Chief Executive Officer (April 22, 2025)
- Tagworks Pharmaceuticals Appoints Keith Orford as Chief Medical Officer (April 22, 2025)
- Theradaptive Appoints Daniel Wolf as Chief Financial Officer (April 22, 2025)
Who to call at Cassava Sciences, and when
A new leader at Cassava Sciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cassava Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cassava Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cassava Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cassava Sciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cassava Sciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.